|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
April 28, 2006
TYSABRI: "Mary Carraux misses the drug she took for more than two months in an attempt to slow her MS"
I felt like a million bucks on the drug; it was the best I ever felt," said Carraux, 47. "My everyday symptoms were so much lighter." The Holmen, Wis., woman used Tysabri, which was withdrawn in February 2005 after only four months on the market when three people in clinical trials developed a rare disease, PML. Two died, including a person with MS....." |